Company Valuation: The Chemours Company

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,958 4,078 5,469 4,621 4,682 2,679 - -
Change - 37.87% 34.11% -15.5% 1.31% -42.77% - -
Enterprise Value (EV) 1 6,175 6,999 7,767 7,134 7,517 5,925 5,977 5,901
Change - 13.35% 10.97% -8.15% 5.36% -21.18% 0.88% -1.27%
P/E ratio -56.5x 18.8x 9.32x 8.39x -19.7x - 6.72x 4.89x
PBR 4.29x 5.03x 5x 4.11x 6.36x 4.21x 3.69x 2.93x
PEG - -0x 0x 6.04x 0x - - 0.1x
Capitalization / Revenue 0.54x 0.82x 0.86x 0.68x 0.78x 0.47x 0.44x 0.42x
EV / Revenue 1.12x 1.41x 1.22x 1.05x 1.25x 1.04x 0.97x 0.93x
EV / EBITDA 6.05x 7.96x 5.92x 5.24x 7.41x 7.68x 5.71x 5.2x
EV / EBIT 8.71x 12.5x 7.8x 6.67x 10.6x 12.5x 8.09x 7.33x
EV / FCF 36.5x 13x 14.3x 16x 40.4x -8.1x 31.4x 17.4x
FCF Yield 2.74% 7.72% 6.99% 6.27% 2.47% -12.3% 3.19% 5.75%
Dividend per Share 2 1 1 1 1 - 0.9938 1.017 1.048
Rate of return 5.53% 4.03% 2.98% 3.27% - 5.54% 5.67% 5.84%
EPS 2 -0.32 1.32 3.6 3.65 -1.6 - 2.67 3.67
Distribution rate -313% 75.8% 27.8% 27.4% - - 38.1% 28.6%
Net sales 1 5,526 4,969 6,345 6,794 6,027 5,712 6,135 6,374
EBITDA 1 1,020 879 1,313 1,361 1,014 771.6 1,047 1,135
EBIT 1 709 559 996 1,070 707 473.5 739 805.3
Net income -52 - 608 578 -238 - 410 563
Net Debt 1 3,217 2,921 2,298 2,513 2,835 3,245 3,297 3,221
Reference price 2 18.09 24.79 33.56 30.62 31.54 17.95 17.95 17.95
Nbr of stocks (in thousands) 163,501 164,496 162,961 150,918 148,438 149,270 - -
Announcement Date 2/13/20 2/11/21 2/10/22 2/9/23 3/27/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
19.44x3.73x9.13x+2.01%80.98B
16.86x0.86x7.05x+7.79%43.15B
36.11x3.16x12.71x+1.87%34.01B
77.72x12.25x53.18x+0.53%20.07B
14.16x1.75x9.05x+3.17%12.04B
14.58x0.73x7.96x+3.31%10.39B
12.34x0.71x6.11x+3.53%10.07B
15.68x0.71x6.02x+3.58%9.06B
45.5x5.17x25.14x+0.31%8.72B
Average 28.04x 3.23x 15.15x +2.90% 25.39B
Weighted average by Cap. 26.59x 3.41x 13.44x +3.13%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. CC Stock
  4. Valuation The Chemours Company
-40% Exceptional Extension: Our subscriptions help you unlock hidden opportunities. Exceptional extension!
BENEFIT NOW